Mesenchymal stem cells and their use in therapy: What has been achieved?
The considerable therapeutic potential of human multipotent mesenchymal stromal cells or mesenchymal stem cells (MSCs) has generated increasing interest in a wide variety of biomedical disciplines. Nevertheless, researchers report studies on MSCs using different methods of isolation and expansion, a...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
2013
|
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 39830caa a22029297a 4500 | ||
|---|---|---|---|
| 001 | PAPER-24403 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230607131918.0 | ||
| 008 | 190411s2013 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-84872246856 | |
| 024 | 7 | |2 cas |a 5' nucleotidase, 9027-73-0; toll like receptor 4, 203811-83-0 | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a DFFNA | ||
| 100 | 1 | |a Fernández Vallone, V.B. | |
| 245 | 1 | 0 | |a Mesenchymal stem cells and their use in therapy: What has been achieved? |
| 260 | |c 2013 | ||
| 270 | 1 | 0 | |m Chasseing, N.A.2490 Vuelta de Obligado, Ciudad Autonoma de Buenos Aires (1428), Buenos Aires, Argentina; email: achasseing@ibyme.conicet.gov.ar |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Abrams, M.B., Dominguez, C., Pernold, K., Reger, R., Wiesenfeld-Hallin, Z., Olson, L., Prockop, D., Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury (2009) Restorative Neurology and Neuroscience, 27, pp. 307-321 | ||
| 504 | |a Aggarwal, S., Pittenger, M.F., Human mesenchymal stem cells modulate allogeneic immune cell responses (2005) Blood, 105, pp. 1815-1822 | ||
| 504 | |a Alaiti, M.A., Ishikawa, M., Costa, M.A., Bone marrow and circulating stem/progenitor cells for regenerative cardiovascular therapy (2010) Translational Research, 156, pp. 112-129 | ||
| 504 | |a Alhadlaq, A., Mao, J.J., Mesenchymal stem cells: isolation and therapeutics (2004) Stem Cells and Development, 13, pp. 436-448 | ||
| 504 | |a Alphonso, A., Alahari, S.K., Stromal cells and integrins: conforming to the needs of the tumor microenvironment (2009) Neoplasia (New York, NY), 11, pp. 1264-1271 | ||
| 504 | |a Myelofibrosis and the biology of connective tissue (1984) Progress in Clinical and Biological Research, 154, pp. 1-500. , Anonymous | ||
| 504 | |a Aranda, P., Agirre, X., Ballestar, E., Andreu, E.J., Roman-Gomez, J., Prieto, I., Martin-Subero, J.I., Prosper, F., Epigenetic signatures associated with different levels of differentiation potential in human stem cells (2009) PLoS One, 4, pp. e7809 | ||
| 504 | |a Baksh, D., Song, L., Tuan, R.S., Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy (2004) Journal of Cellular and Molecular Medicine, 8, pp. 301-316 | ||
| 504 | |a Barry, F., Boynton, R., Murphy, M., Haynesworth, S., Zaia, J., The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells (2001) Biochemical and Biophysical Research Communications, 289, pp. 519-524 | ||
| 504 | |a Bernardo, M.E., Zaffaroni, N., Novara, F., Cometa, A.M., Avanzini, M.A., Moretta, A., Montagna, D., Locatelli, F., Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms (2007) Cancer Research, 67, pp. 9142-9149 | ||
| 504 | |a Bianco, P., Robey, P.G., Saggio, I., Riminucci, M., "Mesenchymal" stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease (2010) Human Gene Therapy, 21, pp. 1057-1066 | ||
| 504 | |a Bianco, P., Sacchetti, B., Riminucci, M., Osteoprogenitors and the hematopoietic microenvironment (2011) Best Practice and Research Clinical Haematology, 24, pp. 37-47 | ||
| 504 | |a Boiret, N., Rapatel, C., Veyrat-Masson, R., Guillouard, L., Guerin, J.J., Pigeon, P., Descamps, S., Berger, M.G., Characterization of nonexpanded mesenchymal progenitor cells from normal adult human bone marrow (2005) Experimental Hematology, 33, pp. 219-225 | ||
| 504 | |a Bruno, S., Grange, C., Deregibus, M.C., Calogero, R.A., Saviozzi, S., Collino, F., Morando, L., Camussi, G., Mesenchymal stem cell-derived microvesicles protect against acute tubular injury (2009) Journal of the American Society of Nephrology, 20, pp. 1053-1067 | ||
| 504 | |a Buhring, H.J., Battula, V.L., Treml, S., Schewe, B., Kanz, L., Vogel, W., Novel markers for the prospective isolation of human MSC (2007) Annals of the New York Academy of Sciences, 1106, pp. 262-271 | ||
| 504 | |a Buhring, H.J., Treml, S., Cerabona, F., de Zwart, P., Kanz, L., Sobiesiak, M., Phenotypic characterization of distinct human bone marrow-derived MSC subsets (2009) Annals of the New York Academy of Sciences, 1176, pp. 124-134 | ||
| 504 | |a Caplan, A.I., The mesengenic process (1994) Clinics in Plastic Surgery, 21, pp. 429-435 | ||
| 504 | |a Castro-Malaspina, H., Gay, R.E., Resnick, G., Kapoor, N., Meyers, P., Chiarieri, D., McKenzie, S., Moore, M.A., Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny (1980) Blood, 56, pp. 289-301 | ||
| 504 | |a Colter, D.C., Class, R., DiGirolamo, C.M., Prockop, D.J., Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow (2000) Proceedings of the National Academy of Sciences of the United States of America, 97, pp. 3213-3218 | ||
| 504 | |a Compston, J.E., Bone marrow and bone: a functional unit (2002) The Journal of endocrinology, 173, pp. 387-394 | ||
| 504 | |a Corcione, A., Benvenuto, F., Ferretti, E., Giunti, D., Cappiello, V., Cazzanti, F., Risso, M., Uccelli, A., Human mesenchymal stem cells modulate B-cell functions (2006) Blood, 107, pp. 367-372 | ||
| 504 | |a Chan, J.L., Tang, K.C., Patel, A.P., Bonilla, L.M., Pierobon, N., Ponzio, N.M., Rameshwar, P., Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma (2006) Blood, 107, pp. 4817-4824 | ||
| 504 | |a Chang, Y.J., Shih, D.T., Tseng, C.P., Hsieh, T.B., Lee, D.C., Hwang, S.M., Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood (2006) Stem Cells, 24, pp. 679-685 | ||
| 504 | |a Charbord, P., Bone marrow mesenchymal stem cells: historical overview and concepts (2010) Human Gene Therapy, 21, pp. 1045-1056 | ||
| 504 | |a Chen, L., Zhang, W., Yue, H., Han, Q., Chen, B., Shi, M., Li, J., Zhao, R.C., Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells (2007) Stem Cells and Development, 16, pp. 719-731 | ||
| 504 | |a Chopp, M., Li, Y., Zhang, Z.G., Mechanisms underlying improved recovery of neurological function after stroke in the rodent after treatment with neurorestorative cell-based therapies (2009) Stroke, 40, pp. S143-145 | ||
| 504 | |a De Becker, A., Van Hummelen, P., Bakkus, M., Vande Broek, I., De Wever, J., De Waele, M., Van Riet, I., Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3 (2007) Haematologica, 92, pp. 440-449 | ||
| 504 | |a Dexter, T.M., Allen, T.D., Lajtha, L.G., Conditions controlling the proliferation of haemopoietic stem cells in vitro (1977) Journal of Cellular Physiology, 91, pp. 335-344 | ||
| 504 | |a Dexter, T.M., Wright, E.G., Krizsa, F., Lajtha, L.G., Regulation of haemopoietic stem cell proliferation in long term bone marrow cultures (1977) Biomedicine, 27, pp. 344-349 | ||
| 504 | |a Dickhut, A., Schwerdtfeger, R., Kuklick, L., Ritter, M., Thiede, C., Neubauer, A., Brendel, C., Mesenchymal stem cells obtained after bone marrow transplantation or peripheral blood stem cell transplantation originate from host tissue (2005) Annals of Hematology, 84, pp. 722-727 | ||
| 504 | |a Ding, Y., Xu, D., Feng, G., Bushell, A., Muschel, R.J., Wood, K.J., Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9 (2009) Diabetes, 58, pp. 1797-1806 | ||
| 504 | |a Djouad, F., Charbonnier, L.M., Bouffi, C., Louis-Plence, P., Bony, C., Apparailly, F., Cantos, C., Noel, D., Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism (2007) Stem Cells, 25, pp. 2025-2032 | ||
| 504 | |a Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noel, D., Jorgensen, C., Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals (2003) Blood, 102, pp. 3837-3844 | ||
| 504 | |a Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Horwitz, E., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement (2006) Cytotherapy, 8, pp. 315-317 | ||
| 504 | |a Eaves, C.J., Cashman, J.D., Sutherland, H.J., Otsuka, T., Humphries, R.K., Hogge, D.E., Lansdorp, P.L., Eaves, A.C., Molecular analysis of primitive hematopoietic cell proliferation control mechanisms (1991) Annals of the New York Academy of Sciences, 628, pp. 298-306 | ||
| 504 | |a Ezquer, F., Ezquer, M., Simon, V., Pardo, F., Yanez, A., Carpio, D., Conget, P., Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice (2009) Biology of Blood and Marrow Transplantation, 15, pp. 1354-1365 | ||
| 504 | |a Fibbe, W.E., Noort, W.A., Mesenchymal stem cells and hematopoietic stem cell transplantation (2003) Annals of the New York Academy of Sciences, 996, pp. 235-244 | ||
| 504 | |a Fox, J.M., Chamberlain, G., Ashton, B.A., Middleton, J., Recent advances into the understanding of mesenchymal stem cell trafficking (2007) British Journal of Haematology, 137, pp. 491-502 | ||
| 504 | |a Galotto, M., Berisso, G., Delfino, L., Podesta, M., Ottaggio, L., Dallorso, S., Dufour, C., Quarto, R., Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients (1999) Experimental Hematology, 27, pp. 1460-1466 | ||
| 504 | |a Gang, E.J., Bosnakovski, D., Figueiredo, C.A., Visser, J.W., Perlingeiro, R.C., SSEA-4 identifies mesenchymal stem cells from bone marrow (2007) Blood, 109, pp. 1743-1751 | ||
| 504 | |a Ghannam, S., Bouffi, C., Djouad, F., Jorgensen, C., Noel, D., Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications (2010) Stem Cell Research and Therapy, 1, p. 2 | ||
| 504 | |a Gregory, C.A., Prockop, D.J., Spees, J.L., Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation (2005) Experimental Cell Research, 306, pp. 330-335 | ||
| 504 | |a Gregory, C.A., Singh, H., Perry, A.S., Prockop, D.J., The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow (2003) The Journal of Biological Chemistry, 278, pp. 28067-28078 | ||
| 504 | |a Gregory, C.A., Ylostalo, J., Prockop, D.J., Adult bone marrow stem/progenitor cells (MSCs) are preconditioned by microenvironmental "niches" in culture: a two-stage hypothesis for regulation of MSC fate (2005) Science STKE 294, pp. e37 | ||
| 504 | |a Helmy, K.Y., Patel, S.A., Silverio, K., Pliner, L., Rameshwar, P., Stem cells and regenerative medicine: accomplishments to date and future promise (2010) Therapeutic Delivery, 1, pp. 693-705 | ||
| 504 | |a Ho, A.D., Wagner, W., Franke, W., Heterogeneity of mesenchymal stromal cell preparations (2008) Cytotherapy, 10, pp. 320-330 | ||
| 504 | |a Hofer, E., Chudzinski-Tavassi, A.M., Bullorsky, O.E., Bordenave, R.H., Chasseing, N.A., MMPs and tissue inhibitors in conditioned mediums from bone marrow CFU-F of advanced lung and breast cancer patients (2002) The Hematology Journal, 3, p. 57 | ||
| 504 | |a Honczarenko, M., Le, Y., Swierkowski, M., Ghiran, I., Glodek, A.M., Silberstein, L.E., Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors (2006) Stem Cells, 24, pp. 1030-1041 | ||
| 504 | |a Horwitz, E.M., Dominici, M., How do mesenchymal stromal cells exert their therapeutic benefit? (2008) Cytotherapy, 10, pp. 771-774 | ||
| 504 | |a Horwitz, E.M., Gordon, P.L., Koo, W.K., Marx, J.C., Neel, M.D., McNall, R.Y., Muul, L., Hofmann, T., Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone (2002) Proceedings of the National Academy of Sciences of the United States of America, 99, pp. 8932-8937 | ||
| 504 | |a Jacobsen, K., Kravitz, J., Kincade, P.W., Osmond, D.G., Adhesion receptors on bone marrow stromal cells: in vivo expression of vascular cell adhesion molecule-1 by reticular cells and sinusoidal endothelium in normal and gamma-irradiated mice (1996) Blood, 87, pp. 73-82 | ||
| 504 | |a Janowska-Wieczorek, A., Majka, M., Ratajczak, J., Ratajczak, M.Z., Autocrine/paracrine mechanisms in human hematopoiesis (2001) Stem Cells, 19, pp. 99-107 | ||
| 504 | |a Jiang, X.X., Zhang, Y., Liu, B., Zhang, S.X., Wu, Y., Yu, X.D., Mao, N., Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells (2005) Blood, 105, pp. 4120-4126 | ||
| 504 | |a Jiang, Y., Jahagirdar, B.N., Reinhardt, R.L., Schwartz, R.E., Keene, C.D., Ortiz-Gonzalez, X.R., Reyes, M., Verfaillie, C.M., Pluripotency of mesenchymal stem cells derived from adult marrow (2002) Nature, 418, pp. 41-49 | ||
| 504 | |a Jones, E., McGonagle, D., Human bone marrow mesenchymal stem cells in vivo (2008) Rheumatology (Oxford), 47, pp. 126-131 | ||
| 504 | |a Karp, J.M., Leng Teo, G.S., Mesenchymal stem cell homing: the devil is in the details (2009) Cell Stem Cell, 4, pp. 206-216 | ||
| 504 | |a Kasper, G., Glaeser, J.D., Geissler, S., Ode, A., Tuischer, J., Matziolis, G., Perka, C., Duda, G.N., Matrix metalloprotease activity is an essential link between mechanical stimulus and mesenchymal stem cell behavior (2007) Stem Cells, 25, pp. 1985-1994 | ||
| 504 | |a Kasten, P., Beyen, I., Egermann, M., Suda, A.J., Moghaddam, A.A., Zimmermann, G., Luginbuhl, R., Instant stem cell therapy: characterization and concentration of human mesenchymal stem cells in vitro (2008) European Cells and Materials, 16, pp. 47-55 | ||
| 504 | |a Kidd, S., Spaeth, E., Dembinski, J.L., Dietrich, M., Watson, K., Klopp, A., Battula, V.L., Marini, F.C., Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging (2009) Stem Cells, 27, pp. 2614-2623 | ||
| 504 | |a Kidd, S., Spaeth, E., Klopp, A., Andreeff, M., Hall, B., Marini, F.C., The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe (2008) Cytotherapy, 10, pp. 657-667 | ||
| 504 | |a Kim, D.H., Yoo, K.H., Choi, K.S., Choi, J., Choi, S.Y., Yang, S.E., Yang, Y.S., Koo, H.H., Gene expression profile of cytokine and growth factor during differentiation of bone marrow-derived mesenchymal stem cell (2005) Cytokine, 31, pp. 119-126 | ||
| 504 | |a Kim, J., Kang, J.W., Park, J.H., Choi, Y., Choi, K.S., Park, K.D., Baek, D.H., Kim, H.S., Biological characterization of long-term cultured human mesenchymal stem cells (2009) Archives of Pharmacal Research, 32, pp. 117-126 | ||
| 504 | |a Koc, O.N., Gerson, S.L., Cooper, B.W., Dyhouse, S.M., Haynesworth, S.E., Caplan, A.I., Lazarus, H.M., Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy (2000) Journal of Clinical Oncology, 18, pp. 307-316 | ||
| 504 | |a Koh, S.H., Noh, M.Y., Cho, G.W., Kim, K.S., Kim, S.H., Erythropoietin increases the motility of human bone marrow-multipotent stromal cells (hBM-MSCs) and enhances the production of neurotrophic factors from hBM-MSCs (2009) Stem Cells and Development, 18, pp. 411-421 | ||
| 504 | |a Korbling, M., Estrov, Z., Adult stem cells for tissue repair-a new therapeutic concept? (2003) The New England Journal of Medicine, 349, pp. 570-582 | ||
| 504 | |a Kortesidis, A., Zannettino, A., Isenmann, S., Shi, S., Lapidot, T., Gronthos, S., Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells (2005) Blood, 105, pp. 3793-3801 | ||
| 504 | |a Krause, U., Harter, C., Seckinger, A., Wolf, D., Reinhard, A., Bea, F., Dengler, T., Hansen, A., Intravenous delivery of autologous mesenchymal stem cells limits infarct size and improves left ventricular function in the infarcted porcine heart (2007) Stem Cells and Development, 16, pp. 31-37 | ||
| 504 | |a Krebsbach, P.H., Kuznetsov, S.A., Bianco, P., Robey, P.G., Bone marrow stromal cells: characterization and clinical application (1999) Critical Reviews in Oral Biology and Medicine, 10, pp. 165-181 | ||
| 504 | |a Kruse, M., Rosorius, O., Kratzer, F., Bevec, D., Kuhnt, C., Steinkasserer, A., Schuler, G., Hauber, J., Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA (2000) The Journal of Experimental Medicine, 191, pp. 1581-1590 | ||
| 504 | |a Kuci, S., Kuci, Z., Kreyenberg, H., Deak, E., Putsch, K., Huenecke, S., Amara, C., Bader, P., CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties (2010) Haematologica, 95, pp. 651-659 | ||
| 504 | |a La Russa, V.F., Schwarzenberger, P., Miller, A., Agrawal, K., Kolls, J., Weiner, R., Marrow stem cells, mesenchymal progenitor cells, and stromal progeny (2002) Cancer Investigation, 20, pp. 110-123 | ||
| 504 | |a Larson, B.L., Ylostalo, J., Prockop, D.J., Human multipotent stromal cells undergo sharp transition from division to development in culture (2008) Stem Cells, 26, pp. 193-201 | ||
| 504 | |a Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Ringden, O., Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study (2008) Lancet, 371, pp. 1579-1586 | ||
| 504 | |a Le Blanc, K., Rasmusson, I., Gotherstrom, C., Seidel, C., Sundberg, B., Sundin, M., Rosendahl, K., Ringden, O., Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes (2004) Scandinavian Journal of Immunology, 60, pp. 307-315 | ||
| 504 | |a Le Blanc, K., Rasmusson, I., Sundberg, B., Gotherstrom, C., Hassan, M., Uzunel, M., Ringden, O., Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells (2004) Lancet, 363, pp. 1439-1441 | ||
| 504 | |a Le Blanc, K., Ringden, O., Immunomodulation by mesenchymal stem cells and clinical experience (2007) Journal of Internal Medicine, 262, pp. 509-525 | ||
| 504 | |a Le Blanc, K., Tammik, L., Sundberg, B., Haynesworth, S.E., Ringden, O., Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex (2003) Scandinavian Journal of Immunology, 57, pp. 11-20 | ||
| 504 | |a Lee, J.W., Fang, X., Gupta, N., Serikov, V., Matthay, M.A., Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung (2009) Proceedings of the National Academy of Sciences of the United States of America, 106, pp. 16357-16362 | ||
| 504 | |a Lee, R.H., Oh, J.Y., Choi, H., Bazhanov, N., Therapeutic factors secreted by mesenchymal stromal cells and tissue repair (2011) Journal of Cellular Biochemistry, 112, pp. 3073-3078 | ||
| 504 | |a Lee, R.H., Seo, M.J., Reger, R.L., Spees, J.L., Pulin, A.A., Olson, S.D., Prockop, D.J., Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice (2006) Proceedings of the National Academy of Sciences of the United States of America, 103, pp. 17438-17443 | ||
| 504 | |a Lepelletier, Y., Lecourt, S., Renand, A., Arnulf, B., Vanneaux, V., Fermand, J.P., Menasche, P., Larghero, J., Galectin-1 and semaphorin-3A are two soluble factors conferring T-cell immunosuppression to bone marrow mesenchymal stem cell (2010) Stem Cells and Development, 19, pp. 1075-1079 | ||
| 504 | |a Li, H., Guo, Z., Jiang, X., Zhu, H., Li, X., Mao, N., Mesenchymal stem cells alter migratory property of T and dendritic cells to delay the development of murine lethal acute graft-versus-host disease (2008) Stem Cells, 26, pp. 2531-2541 | ||
| 504 | |a Li, J., Kwong, D.L., Chan, G.C., The effects of various irradiation doses on the growth and differentiation of marrow-derived human mesenchymal stromal cells (2007) Pediatric Transplantation, 11, pp. 379-387 | ||
| 504 | |a Maccario, R., Podesta, M., Moretta, A., Cometa, A., Comoli, P., Montagna, D., Daudt, L., Locatelli, F., Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype (2005) Haematologica, 90, pp. 516-525 | ||
| 504 | |a Mackay, A.M., Beck, S.C., Murphy, J.M., Barry, F.P., Chichester, C.O., Pittenger, M.F., Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow (1998) Tissue Engineering, 4, pp. 415-428 | ||
| 504 | |a Majumdar, M.K., Thiede, M.A., Mosca, J.D., Moorman, M., Gerson, S.L., Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells (1998) Journal of Cellular Physiology, 176, pp. 57-66 | ||
| 504 | |a Matthay, M.A., Advances and challenges in translating stem cell therapies for clinical diseases (2010) Translational Research, 156, pp. 107-111 | ||
| 504 | |a Mayani, H., Guilbert, L.J., Janowska-Wieczorek, A., Biology of the hemopoietic microenvironment (1992) European Journal of Haematology, 49, pp. 225-233 | ||
| 504 | |a Mendez-Ferrer, S., Michurina, T.V., Ferraro, F., Mazloom, A.R., Macarthur, B.D., Lira, S.A., Scadden, D.T., Frenette, P.S., Mesenchymal and haematopoietic stem cells form a unique bone marrow niche (2010) Nature, 466, pp. 829-834 | ||
| 504 | |a Minguell, J.J., Erices, A., Conget, P., Mesenchymal stem cells (2001) Experimental Biology and Medicine (Maywood), 226, pp. 507-520 | ||
| 504 | |a Mueller, S.M., Glowacki, J., Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges (2001) Journal of Cellular Biochemistry, 82, pp. 583-590 | ||
| 504 | |a Muraglia, A., Corsi, A., Riminucci, M., Mastrogiacomo, M., Cancedda, R., Bianco, P., Quarto, R., Formation of a chondro-osseous rudiment in micromass cultures of human bone-marrow stromal cells (2003) Journal of Cell Science, 116, pp. 2949-2955 | ||
| 504 | |a Myers, T.J., Granero-Molto, F., Longobardi, L., Li, T., Yan, Y., Spagnoli, A., Mesenchymal stem cells at the intersection of cell and gene therapy (2010) Expert Opinion on Biological Therapy, 10, pp. 1663-1679 | ||
| 504 | |a Nauta, A.J., Fibbe, W.E., Immunomodulatory properties of mesenchymal stromal cells (2007) Blood, 110, pp. 3499-3506 | ||
| 504 | |a Nauta, A.J., Kruisselbrink, A.B., Lurvink, E., Willemze, R., Fibbe, W.E., Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells (2006) Journal of Immunology, 177, pp. 2080-2087 | ||
| 504 | |a Neuhuber, B., Swanger, S.A., Howard, L., Mackay, A., Fischer, I., Effects of plating density and culture time on bone marrow stromal cell characteristics (2008) Experimental Hematology, 36, pp. 1176-1185 | ||
| 504 | |a Ng, F., Boucher, S., Koh, S., Sastry, K.S., Chase, L., Lakshmipathy, U., Choong, C., Tanavde, V., PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages (2008) Blood, 112, pp. 295-307 | ||
| 504 | |a Parekkadan, B., Milwid, J.M., Mesenchymal stem cells as therapeutics (2010) Annual Review of Biomedical Engineering, 12, pp. 87-117 | ||
| 504 | |a Parekkadan, B., Tilles, A.W., Yarmush, M.L., Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells (2008) Stem Cells, 26, pp. 1913-1919 | ||
| 504 | |a Patel, S.A., Sherman, L., Munoz, J., Rameshwar, P., Immunological properties of mesenchymal stem cells and clinical implications (2008) Archivum Immunologiae et Therapiae Experimentalis (Warsz), 56, pp. 1-8 | ||
| 504 | |a Pereira, R.F., O'Hara, M.D., Laptev, A.V., Halford, K.W., Pollard, M.D., Class, R., Simon, D., Prockop, D.J., Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta (1998) Proceedings of the National Academy of Sciences of the United States of America, 95, pp. 1142-1147 | ||
| 504 | |a Pevsner-Fischer, M., Levin, S., Zipori, D., The origins of mesenchymal stromal cell heterogeneity (2011) Stem Cell Reviews, 7, pp. 560-568 | ||
| 504 | |a Ponte, A.L., Marais, E., Gallay, N., Langonne, A., Delorme, B., Herault, O., Charbord, P., Domenech, J., The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities (2007) Stem Cells, 25, pp. 1737-1745 | ||
| 504 | |a Potian, J.A., Aviv, H., Ponzio, N.M., Harrison, J.S., Rameshwar, P., Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens (2003) Journal of Immunology, 171, pp. 3426-3434 | ||
| 504 | |a Pountos, I., Giannoudis, P.V., Biology of mesenchymal stem cells (2005) Injury, 36 (SUPPL. 3), pp. S8-S12 | ||
| 504 | |a Prindull, G., Hypothesis: cell plasticity, linking embryonal stem cells to adult stem cell reservoirs and metastatic cancer cells? (2005) Experimental Hematology, 33, pp. 738-746 | ||
| 504 | |a Prockop, D.J., "Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs) (2007) Clinical Pharmacology and Therapeutics, 82, pp. 241-243 | ||
| 504 | |a Prockop, D.J., Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms (2009) Molecular Therapy, 17, pp. 939-946 | ||
| 504 | |a Prockop, D.J., Defining the probability that a cell therapy will produce a malignancy (2010) Molecular Therapy, 18, pp. 1249-1250 | ||
| 504 | |a Prockop, D.J., Brenner, M., Fibbe, W.E., Horwitz, E., Le Blanc, K., Phinney, D.G., Simmons, P.J., Keating, A., Defining the risks of mesenchymal stromal cell therapy (2010) Cytotherapy, 12, pp. 576-578 | ||
| 504 | |a Prockop, D.J., Kota, D.J., Bazhanov, N., Reger, R.L., Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs) (2010) Journal of Cellular and Molecular Medicine, 14, pp. 2190-2199 | ||
| 504 | |a Rasmusson, I., Le Blanc, K., Sundberg, B., Ringden, O., Mesenchymal stem cells stimulate antibody secretion in human B cells (2007) Scandinavian Journal of Immunology, 65, pp. 336-343 | ||
| 504 | |a Ren, G., Su, J., Zhang, L., Zhao, X., Ling, W., L'Huillie, A., Zhang, J., Shi, Y., Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression (2009) Stem Cells, 27, pp. 1954-1962 | ||
| 504 | |a Ren, G., Zhao, X., Zhang, L., Zhang, J., L'Huillier, A., Ling, W., Roberts, A.I., Shi, Y., Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression (2010) Journal of Immunology, 184, pp. 2321-2328 | ||
| 504 | |a Rougier, F., Dupuis, F., Denizot, Y., Human bone marrow fibroblasts-an overview of their characterization, proliferation and inflammatory mediator production (1996) Hematology and Cell Therapy, 38, pp. 241-246 | ||
| 504 | |a Russell, K.C., Phinney, D.G., Lacey, M.R., Barrilleaux, B.L., Meyertholen, K.E., O'Connor, K.C., In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment (2010) Stem Cells, 28, pp. 788-798 | ||
| 504 | |a Ruster, B., Gottig, S., Ludwig, R.J., Bistrian, R., Muller, S., Seifried, E., Gille, J., Henschler, R., Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells (2006) Blood, 108, pp. 3938-3944 | ||
| 504 | |a Sacchetti, B., Funari, A., Michienzi, S., Di Cesare, S., Piersanti, S., Saggio, I., Tagliafico, E., Bianco, P., Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment (2007) Cell, 131, pp. 324-336 | ||
| 504 | |a Schmidt, A., Ladage, D., Schinkothe, T., Klausmann, U., Ulrichs, C., Klinz, F.J., Brixius, K., Bloch, W., Basic fibroblast growth factor controls migration in human mesenchymal stem cells (2006) Stem Cells, 24, pp. 1750-1758 | ||
| 504 | |a Schwarz, S.C., Schwarz, J., Translation of stem cell therapy for neurological diseases (2010) Translational Research, 156, pp. 155-160 | ||
| 504 | |a Sekiya, I., Larson, B.L., Smith, J.R., Pochampally, R., Cui, J.G., Prockop, D.J., Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality (2002) Stem Cells, 20, pp. 530-541 | ||
| 504 | |a Shaker, A., Rubin, D.C., Intestinal stem cells and epithelial-mesenchymal interactions in the crypt and stem cell niche (2010) Translational Research, 156, pp. 180-187 | ||
| 504 | |a Simmons, P.J., Przepiorka, D., Thomas, E.D., Torok-Storb, B., Host origin of marrow stromal cells following allogeneic bone marrow transplantation (1987) Nature, 328, pp. 429-432 | ||
| 504 | |a Sorrentino, A., Ferracin, M., Castelli, G., Biffoni, M., Tomaselli, G., Baiocchi, M., Fatica, A., Valtieri, M., Isolation and characterization of CD146+ multipotent mesenchymal stromal cells (2008) Experimental Hematology, 36, pp. 1035-1046 | ||
| 504 | |a Steingen, C., Brenig, F., Baumgartner, L., Schmidt, J., Schmidt, A., Bloch, W., Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells (2008) Journal of Molecular and Cellular Cardiology, 44, pp. 1072-1084 | ||
| 504 | |a Sueblinvong, V., Weiss, D.J., Stem cells and cell therapy approaches in lung biology and diseases (2010) Translational Research, 156, pp. 188-205 | ||
| 504 | |a Taichman, R.S., Emerson, S.G., The role of osteoblasts in the hematopoietic microenvironment (1998) Stem Cells, 16, pp. 7-15 | ||
| 504 | |a Tamama, K., Fan, V.H., Griffith, L.G., Blair, H.C., Wells, A., Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells (2006) Stem Cells, 24, pp. 686-695 | ||
| 504 | |a Tocci, A., Forte, L., Mesenchymal stem cell: use and perspectives (2003) The Hematology Journal, 4, pp. 92-96 | ||
| 504 | |a Togel, F., Westenfelder, C., Stem cells in acute kidney injury repair (2009) Minerva Urologica e Nefrologica, 61, pp. 205-213 | ||
| 504 | |a Tuli, R., Tuli, S., Nandi, S., Huang, X., Manner, P.A., Hozack, W.J., Danielson, K.G., Tuan, R.S., Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk (2003) The Journal of Biological Chemistry, 278, pp. 41227-41236 | ||
| 504 | |a Uccelli, A., Prockop, D.J., Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? (2010) Current Opinion in Immunology, 22, pp. 768-774 | ||
| 504 | |a Van Overstraeten-Schlogel, N., Beguin, Y., Gothot, A., Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells (2006) European Journal of Haematology, 76, pp. 488-493 | ||
| 504 | |a Wagers, A.J., Weissman, I.L., Plasticity of adult stem cells (2004) Cell, 116, pp. 639-648 | ||
| 504 | |a Wang, Q.R., Wang, B.H., Zhu, W.B., Huang, Y.H., Li, Y., Yan, Q., An in vitro study of differentiation of hematopoietic cells to endothelial cells (2011) Bone Marrow Research, 2011, pp. 846096-846104 | ||
| 504 | |a Wang, R., Stromer, M.H., Huiatt, T.W., Integrin expression in developing smooth muscle cells (1998) The Journal of Histochemistry and Cytochemistry, 46, pp. 119-126 | ||
| 504 | |a Waterman, R.S., Tomchuck, S.L., Henkle, S.L., Betancourt, A.M., A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype (2010) PLoS One, 5, pp. e10088 | ||
| 504 | |a Whetton, A.D., Dexter, T.M., Influence of growth factors and substrates on differentiation of haemopoietic stem cells (1993) Current Opinion in Cell Biology, 5, pp. 1044-1049 | ||
| 504 | |a Wong, R.S., Mesenchymal stem cells: angels or demons? (2011) Journal of Biomedicine and Biotechnology, 2011, pp. 459510-459517 | ||
| 504 | |a Yagi, H., Soto-Gutierrez, A., Parekkadan, B., Kitagawa, Y., Tompkins, R.G., Kobayashi, N., Yarmush, M.L., Mesenchymal stem cells: mechanisms of immunomodulation and homing (2010) Cell Transplantation, 19, pp. 667-679 | ||
| 504 | |a Yamada, M., Suzu, S., Tanaka-Douzono, M., Wakimoto, N., Hatake, K., Hayasawa, H., Motoyoshi, K., Effect of cytokines on the proliferation/differentiation of stroma-initiating cells (2000) Journal of Cellular Physiology, 184, pp. 351-355 | ||
| 504 | |a Ylostalo, J., Bazhanov, N., Prockop, D.J., Reversible commitment to differentiation by human multipotent stromal cells in single-cell-derived colonies (2008) Experimental Hematology, 36, pp. 1390-1402 | ||
| 504 | |a Zappia, E., Casazza, S., Pedemonte, E., Benvenuto, F., Bonanni, I., Gerdoni, E., Giunti, D., Uccelli, A., Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy (2005) Blood, 106, pp. 1755-1761 | ||
| 504 | |a Zhou, D.H., Huang, S.L., Wu, Y.F., Wei, J., Chen, G.Y., Li, Y., Bao, R., The expansion and biological characteristics of human mesenchymal stem cells (2003) Zhonghua Er Ke Za Zhi, 41, pp. 607-610 | ||
| 504 | |a Zipori, D., Mesenchymal stem cells: harnessing cell plasticity to tissue and organ repair (2004) Blood Cells, Molecules and Diseases, 33, pp. 211-215 | ||
| 504 | |a Zorn, A.M., Wnt signalling: antagonistic Dickkopfs (2001) Current Biology, 11, pp. R592-595 | ||
| 520 | 3 | |a The considerable therapeutic potential of human multipotent mesenchymal stromal cells or mesenchymal stem cells (MSCs) has generated increasing interest in a wide variety of biomedical disciplines. Nevertheless, researchers report studies on MSCs using different methods of isolation and expansion, as well as different approaches to characterize them; therefore, it is increasingly difficult to compare and contrast study outcomes. To begin to address this issue, the Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy proposed minimal criteria to define human MSCs. First, MSCs must be plastic-adherent when maintained in standard culture conditions (α minimal essential medium plus 20% fetal bovine serum). Second, MSCs must express CD105, CD73 and CD90, and MSCs must lack expression of CD45, CD34, CD14 or CD11b, CD79α or CD19 and HLA-DR surface molecules. Third, MSCs must differentiate into osteoblasts, adipocytes and chondroblasts in vitro. MSCs are isolated from many adult tissues, in particular from bone marrow and adipose tissue. Along with their capacity to differentiate and transdifferentiate into cells of different lineages, these cells have also generated great interest for their ability to display immunomodulatory capacities. Indeed, a major breakthrough was the finding that MSCs are able to induce peripheral tolerance, suggesting that they may be used as therapeutic tools in immune-mediated disorders. Although no significant adverse events have been reported in clinical trials to date, all interventional therapies have some inherent risks. Potential risks for undesirable events, such as tumor development, that might occur while using these stem cells for therapy must be taken into account and contrasted against the potential benefits to patients. © 2012 International Society of Differentiation. |l eng | |
| 593 | |a Experimental Biology and Medicine Institute, CONICET, Buenos Aires, Argentina | ||
| 593 | |a Thrombosis I Laboratory, Hematological Research Institute, National Academy of Medicine, CONICET, Buenos Aires, Argentina | ||
| 593 | |a Institute for Regenerative Medicine, Texas A and M Health Sciences Center, Temple, TX, United States | ||
| 593 | |a 2490 Vuelta de Obligado, Ciudad Autonoma de Buenos Aires (1428), Buenos Aires, Argentina | ||
| 593 | |a 3092 Las Heras Avenue, Ciudad Autonoma de Buenos Aires (1425), Buenos Aires, Argentina | ||
| 593 | |a 5701 Airport Road, Module C., Temple, TX 76502, United States | ||
| 690 | 1 | 0 | |a BONE MARROW |
| 690 | 1 | 0 | |a MESENCHYMAL STEM CELLS |
| 690 | 1 | 0 | |a PLASTICITY |
| 690 | 1 | 0 | |a 5' NUCLEOTIDASE |
| 690 | 1 | 0 | |a CD11B ANTIGEN |
| 690 | 1 | 0 | |a CD14 ANTIGEN |
| 690 | 1 | 0 | |a CD19 ANTIGEN |
| 690 | 1 | 0 | |a CD34 ANTIGEN |
| 690 | 1 | 0 | |a CD45 ANTIGEN |
| 690 | 1 | 0 | |a CD79A ANTIGEN |
| 690 | 1 | 0 | |a ENDOGLIN |
| 690 | 1 | 0 | |a HLA DR ANTIGEN |
| 690 | 1 | 0 | |a INTERLEUKIN 10 |
| 690 | 1 | 0 | |a INTERLEUKIN 4 |
| 690 | 1 | 0 | |a THY 1 ANTIGEN |
| 690 | 1 | 0 | |a TOLL LIKE RECEPTOR 3 |
| 690 | 1 | 0 | |a TOLL LIKE RECEPTOR 4 |
| 690 | 1 | 0 | |a TUMOR NECROSIS FACTOR ALPHA |
| 690 | 1 | 0 | |a ACUTE LUNG INJURY |
| 690 | 1 | 0 | |a ADIPOCYTE |
| 690 | 1 | 0 | |a ADIPOSE TISSUE |
| 690 | 1 | 0 | |a ANTIGEN EXPRESSION |
| 690 | 1 | 0 | |a BONE MARROW |
| 690 | 1 | 0 | |a CARTILAGE CELL |
| 690 | 1 | 0 | |a CELL ADHESION |
| 690 | 1 | 0 | |a CELL DIFFERENTIATION |
| 690 | 1 | 0 | |a CELL EXPANSION |
| 690 | 1 | 0 | |a CELL ISOLATION |
| 690 | 1 | 0 | |a CELL LINEAGE |
| 690 | 1 | 0 | |a CELL RENEWAL |
| 690 | 1 | 0 | |a CELL TRANSDIFFERENTIATION |
| 690 | 1 | 0 | |a CEREBROVASCULAR ACCIDENT |
| 690 | 1 | 0 | |a CROHN DISEASE |
| 690 | 1 | 0 | |a CULTURE MEDIUM |
| 690 | 1 | 0 | |a CYTOKINE PRODUCTION |
| 690 | 1 | 0 | |a DIABETES MELLITUS |
| 690 | 1 | 0 | |a HEMATOPOIESIS |
| 690 | 1 | 0 | |a HUMAN |
| 690 | 1 | 0 | |a IMMUNOGENICITY |
| 690 | 1 | 0 | |a IMMUNOLOGICAL TOLERANCE |
| 690 | 1 | 0 | |a IMMUNOMODULATION |
| 690 | 1 | 0 | |a IMMUNOSTIMULATION |
| 690 | 1 | 0 | |a IN VITRO STUDY |
| 690 | 1 | 0 | |a KIDNEY INJURY |
| 690 | 1 | 0 | |a MEDICAL SOCIETY |
| 690 | 1 | 0 | |a MESENCHYMAL STEM CELL |
| 690 | 1 | 0 | |a MESENCHYMAL STEM CELL TRANSPLANTATION |
| 690 | 1 | 0 | |a NONHUMAN |
| 690 | 1 | 0 | |a OSTEOBLAST |
| 690 | 1 | 0 | |a OSTEOGENESIS IMPERFECTA |
| 690 | 1 | 0 | |a PARKINSON DISEASE |
| 690 | 1 | 0 | |a PRIORITY JOURNAL |
| 690 | 1 | 0 | |a REVIEW |
| 690 | 1 | 0 | |a RISK ASSESSMENT |
| 690 | 1 | 0 | |a RISK BENEFIT ANALYSIS |
| 690 | 1 | 0 | |a SPINAL CORD INJURY |
| 690 | 1 | 0 | |a TISSUE REGENERATION |
| 690 | 1 | 0 | |a TUMOR GROWTH |
| 690 | 1 | 0 | |a CELL DIFFERENTIATION |
| 690 | 1 | 0 | |a HUMANS |
| 690 | 1 | 0 | |a MESENCHYMAL STEM CELL TRANSPLANTATION |
| 690 | 1 | 0 | |a MESENCHYMAL STROMAL CELLS |
| 690 | 1 | 0 | |a BOVINAE |
| 700 | 1 | |a Romaniuk, M.A. | |
| 700 | 1 | |a Choi, H. | |
| 700 | 1 | |a Labovsky, V. | |
| 700 | 1 | |a Otaegui, J. | |
| 700 | 1 | |a Chasseing, N.A. | |
| 773 | 0 | |d 2013 |g v. 85 |h pp. 1-10 |k n. 1-2 |p Differentiation |x 03014681 |t Differentiation | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872246856&doi=10.1016%2fj.diff.2012.08.004&partnerID=40&md5=e450ad7475e8f49c00486e1ae7dfd02d |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.diff.2012.08.004 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_03014681_v85_n1-2_p1_FernandezVallone |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03014681_v85_n1-2_p1_FernandezVallone |y Registro en la Biblioteca Digital |
| 961 | |a paper_03014681_v85_n1-2_p1_FernandezVallone |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 85356 | ||